DK1800664T3 - Farmaceutiske formuleringer til parenteral indgivelse indeholdende epothilon - Google Patents

Farmaceutiske formuleringer til parenteral indgivelse indeholdende epothilon

Info

Publication number
DK1800664T3
DK1800664T3 DK07102856T DK07102856T DK1800664T3 DK 1800664 T3 DK1800664 T3 DK 1800664T3 DK 07102856 T DK07102856 T DK 07102856T DK 07102856 T DK07102856 T DK 07102856T DK 1800664 T3 DK1800664 T3 DK 1800664T3
Authority
DK
Denmark
Prior art keywords
pharmaceutical formulations
parenteral administration
administration containing
epothilone
containing epothilone
Prior art date
Application number
DK07102856T
Other languages
Danish (da)
English (en)
Inventor
Hoogevest Peter Van
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10826504&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1800664(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Priority claimed from PCT/EP1999/000702 external-priority patent/WO1999039694A2/en
Application granted granted Critical
Publication of DK1800664T3 publication Critical patent/DK1800664T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK07102856T 1998-02-05 1999-02-03 Farmaceutiske formuleringer til parenteral indgivelse indeholdende epothilon DK1800664T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9802451.6A GB9802451D0 (en) 1998-02-05 1998-02-05 Organic compounds
PCT/EP1999/000702 WO1999039694A2 (en) 1998-02-05 1999-02-03 Compositions containing organic compounds

Publications (1)

Publication Number Publication Date
DK1800664T3 true DK1800664T3 (da) 2009-07-20

Family

ID=10826504

Family Applications (1)

Application Number Title Priority Date Filing Date
DK07102856T DK1800664T3 (da) 1998-02-05 1999-02-03 Farmaceutiske formuleringer til parenteral indgivelse indeholdende epothilon

Country Status (9)

Country Link
EP (1) EP1800664B8 (el)
AT (1) ATE427736T1 (el)
CY (1) CY1109190T1 (el)
DE (1) DE69940708D1 (el)
DK (1) DK1800664T3 (el)
ES (1) ES2324376T3 (el)
GB (1) GB9802451D0 (el)
PT (1) PT1800664E (el)
ZA (1) ZA99874B (el)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4138042C2 (de) * 1991-11-19 1993-10-14 Biotechnolog Forschung Gmbh Epothilone, deren Herstellungsverfahren sowie diese Verbindungen enthaltende Mittel
DE59609305D1 (de) * 1995-11-17 2002-07-11 Biotechnolog Forschung Gmbh Epothilon-Derivate und deren Herstellung
SI0932399T1 (sl) * 1996-03-12 2006-10-31 Pg Txl Co Lp Vodotopna paklitakselna predzdravila
US6441186B1 (en) * 1996-12-13 2002-08-27 The Scripps Research Institute Epothilone analogs
JP4644364B2 (ja) * 1998-02-05 2011-03-02 ノバルティス アーゲー エポシロン組成物

Also Published As

Publication number Publication date
ES2324376T3 (es) 2009-08-05
ZA99874B (en) 1999-08-05
CY1109190T1 (el) 2014-07-02
EP1800664B1 (en) 2009-04-08
DE69940708D1 (de) 2009-05-20
GB9802451D0 (en) 1998-04-01
EP1800664B8 (en) 2010-12-15
PT1800664E (pt) 2009-07-10
EP1800664A1 (en) 2007-06-27
ATE427736T1 (de) 2009-04-15

Similar Documents

Publication Publication Date Title
MY125921A (en) Compositions containing organic compounds
DK0839026T3 (da) Micellære polyether-blokcopolymerkompositioner til målretning af biologiske midler
NO20025089L (no) Farmasöytiske preparater
CY1110547T1 (el) Συμπυκνωμενα πρωτεϊνικα σκευασματα μειωμενου ιξωδους
GEP20053473B (en) High Potency Dihydroergotamine Compositions
DZ2887A1 (fr) Dérivés d'azétidine, leur préparation et les médicaments les contenant.
DK0703786T3 (da) Anvendelse af nona- og dekapeptider til fremstilling af et lægemiddel til behandling af AIDS
BR0012429A (pt) Fórmulações para il-11
DE60019334D1 (de) Antivirale arznei
DE69923336D1 (de) Oral anzuwendende buprenorphinhaltige arzneimittel
RS49599B (sr) Upotreba inhibitora h+, k+-atp-aze i glukokortikoida i farmaceutska formulacija
MXPA03005221A (es) Composicion farmaceutica de dronedarona para administracion parenteral.
ATE187890T1 (de) Ligandgerichtete enzyme-prodrug therapie
FR2779429B1 (fr) Derives d'oxindole, leurs preparations et leurs applications en therapeutique
DK1800664T3 (da) Farmaceutiske formuleringer til parenteral indgivelse indeholdende epothilon
NO20014692D0 (no) 3-amidinobenzensulfonamidderivater, medisinske sammensetninger inneholdende slike samt intermediater vedfremstillingen derav
ATE208627T1 (de) Orale zusammensetzungen mit niedrigdosierten zytotoxischen proteinen
WO2001022917A8 (en) Effervescent compositions comprising nimesulide
WO2000017366A3 (en) Pharmaceutical composition for the pre-treatment of a patient in need of drug or pro-drug
IT1318578B1 (it) Articolatore, particolarmente per le applicazioni in odontoiatria eodontotecnica.
SE9803107D0 (sv) Novel Compunds
WO1999051253A3 (en) Immune response modulation
ECSP992852A (es) Compuestos organicos
FR2652266B1 (fr) Vaccin protecteur contre l'hemophilose porcine.
CY1106311T1 (el) Χορηγηση απο το στομα παραγωγων ταξοειδων